Skip to main content

Advertisement

SpringerLink
Log in

News letter number 10

  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. European Society of Nuclear Medicine (1984) Newsletter 7. Eur J Nucl Med 9:47

    Google Scholar 

  2. European Society of Nuclear Medicine (1984) Newsletter 8. Eur J Nucl Med 9:308

    Google Scholar 

  3. Joint Committee on Radiopharmaceuticals of the European Nuclear Medicine Society and the Society of Nuclear Medicine-Europe (1982). Nucl Med 21:274

    Google Scholar 

  4. Joint Committee on Radiopharmaceuticals of the European Nuclear Medicine Society and the Society of Nuclear Medicine-Europe (1984). Nucl Med 13:107

    Google Scholar 

  5. European Society of Nuclear Medicine (1987) Newsletter 9. Eur J Nucl Med 13:487–490

    Google Scholar 

  6. Keeling DH, Sampson CB (1984) Adverse reactions to radiopharmaceuticals. United Kingdom 1977–1983. Br J Radiol 57:1091

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

News letter number 10. Eur J Nucl Med 13, 491–492 (1987). https://doi.org/10.1007/BF00281868

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00281868

Search

Navigation